Loading
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
Latest quote
$3.54
+$0.04 · +1.14%
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Previous close
$3.54
+$0.04 · +1.14%
After-hours
$3.4775
−$0.0625 · -1.77%
Sep 8, 7:37 PM ET
Regular session · ET · Market data may be delayed.
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Day range
Current $3.54
52-week range
Current $3.54
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
25
Expensive
Sentiment
53
Mixed
Risk
71
High Risk
Momentum
17
Strong Down
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Day range
Current $3.54
52-week range
Current $3.54
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cost of goods sold | — | — | — | 5.97K USD | 60.83K USD |
| Gross profit | — | — | — | −5.97K USD | −60.83K USD |
| Research and development | 4.05M USD | 3.62M USD | 3.52M USD | 1.05M USD | 1.02M USD |
| Selling, general, and administrative | 7.86M USD | 4.08M USD | 2.38M USD | 1.29M USD | 721.18K USD |
| Operating expenses | 11.92M USD | 7.7M USD | 5.89M USD | 2.34M USD | 1.68M USD |
| Interest income | 1.09K USD | 38.14K USD | 79.12K USD | — | — |
| Interest expense | 70.83K USD | 1.36M USD | 2.6M USD | 670.61K USD | 50.79K USD |
| Depreciation and amortization | 290.11K USD | 5.46K USD | 6.81K USD | 5.97K USD | 60.83K USD |
| Operating income | −11.92M USD | −7.7M USD | −5.89M USD | −2.34M USD | −1.74M USD |
| Net income | −11.72M USD | −9.14M USD | −6.59M USD | −5M USD | −1.15M USD |
Company facts updated Sep 9, 2026.
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | Jun 11, 2026 | 1:10 | — | — |
Stock split | Jun 16, 2025 | 1:25 | — | — |
Stock split | Aug 13, 2024 | 1:8 | — | — |
Effective Jun 11, 2026
1:10
Effective Jun 16, 2025
1:25
Effective Aug 13, 2024
1:8
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
